Skip to main content
Equibles
AMTX logo

AMTX · Aemetis, Inc · Metrics

Track AMTX — free

Use AMTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.72 +0.10 (+5.86%) Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Nov 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Notwithstanding our plans to improve liquidity and the favorable recent events described above, based on the extent of our debt and reliance on our senior secured lender, substantial doubt exists about our ability to continue as a going concern over the next *twelve* months.”
View the 10-Q filed Nov 5, 2026
Market Cap
$118.42M
Shares
73.10M
Volume · Nov 9 299.13K Avg daily vol (3M) 1.06M

AMTX metrics

89 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.62
Market cap
$118.42M

Price action

23 metrics
Price change (1W)
+29.6%
Price change (30D)
-2.4%
Price change (3M)
-5.8%
Price change (6M)
-37.5%
Price change (YTD)
+16.5%
Price change (1Y)
-8.0%
Trailing year
Price change (5Y)
-92.7%
52-week high
$3.66
52-week low
$1.15
Change from 52-week high
-55.7%
Change from 52-week low
+40.9%
Annualized volatility
102.0%
Annualized volatility (3M)
105.8%
Implied volatility (30D)
116.1%
IV rank (1Y)
33.7
IV percentile (1Y)
55.8
Beta
-0.4
RSI (14D)
56.9
Price vs SMA 50
-2.5%
Price vs SMA 200
-17.6%
Avg volume (3M)
1.06M
Relative volume
3.0
Average dollar volume
$1.82M

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
73.10M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.2×
reciprocal yield 45.2%
EV / EBITDA
—
EV / EBIT
30.9×
reciprocal yield 3.2%
P / sales
0.5×
reciprocal yield 210.1%
P / book
—
FCF yield
-30.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
7.7
reciprocal yield 12.9%
Earnings yield
-26.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.2×
reciprocal yield 44.8%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 42.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
21.5%
Operating margin
7.2%
Trailing 12 months
Net margin
-12.5%
Gross profit (TTM)
$53.47M
Operating profit (TTM)
$17.81M
Net income (TTM)
−$31.20M
Trailing 12 months
Diluted EPS (TTM)
$-0.51
FCF margin
-14.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.58
Gross profit per diluted share (TTM)
$0.76
Operating profit per diluted share (TTM)
$0.24
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.47
Operating cash flow per diluted share (TTM)
$0.21
Free cash flow per diluted share (TTM)
$-0.54
Capital expenditures per diluted share (TTM)
$0.75
R&D per diluted share (TTM)
$0.00
Stock compensation per diluted share (TTM)
$0.07
Book value per share
$-4.64

Growth

11 metrics
Revenue growth YoY
+48.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$248.78M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+13.8%
Year over year · more shares
Revenue CAGR (3Y)
+91.6%
Revenue CAGR (5Y)
+3.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-10.0%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$36.58M
Quick ratio
0.0
Interest coverage
0.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$432.09M
Latest balance sheet
Cash & equivalents
$3.36M
Total assets
$312.00M
Total debt
$435.45M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$15.29M
Capital expenditures (TTM)
$51.87M
R&D (TTM)
$152,000
SG&A (TTM)
$35.66M
Stock compensation (TTM)
$4.81M
R&D / revenue
—
Stock compensation / revenue
1.9%

Ownership (13F)

9 metrics
13F filers
89
13F filer change QoQ
+11
Institutional ownership
24.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
4.5%
Private-fund adviser ownership
2.7%
Active holders' share change QoQ
-14.3%
Holder tenure
10.2
Price vs estimated holder cost
-57.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.7%

Short interest

3 metrics
Short interest
11.1%
Latest settlement · 13.6 days to cover
Days to cover
13.6d
Short-squeeze score
100 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 738214 CUSIP 00770K202 13F (30d) 44 filings 32 filers Visit website Investor relations